These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. External validation for fibrosis predicting index in hereditary hemochromatosis. Castiella A; Emparanza JI Am J Gastroenterol; 2005 Oct; 100(10):2366-7. PubMed ID: 16181396 [No Abstract] [Full Text] [Related]
8. Hemochromatosis. Adams PC Clin Liver Dis; 2004 Nov; 8(4):735-53, vii. PubMed ID: 15464653 [TBL] [Abstract][Full Text] [Related]
9. Relationship between iron accumulation and portal fibrosis. Senba M Isr J Med Sci; 1989 Nov; 25(11):650-1. PubMed ID: 2592182 [No Abstract] [Full Text] [Related]
11. [Study of the behavior of radioactive iron in hemochromatosis and alcoholic cirrhosis]. AZERAD E; TUBIANA M; ROSSELIN G; KONDAKIS X; LUBETZKI J; GHATA J Bull Mem Soc Med Hop Paris; 1960 May 13-20; 76():664-9. PubMed ID: 13685409 [No Abstract] [Full Text] [Related]
12. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C. Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937 [TBL] [Abstract][Full Text] [Related]
13. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Milman N; Pedersen P; á Steig T; Byg KE; Graudal N; Fenger K Ann Hematol; 2001 Dec; 80(12):737-44. PubMed ID: 11797115 [TBL] [Abstract][Full Text] [Related]
14. Iron and hepatitis C. Bacon BR Gut; 1997 Jul; 41(1):127-8. PubMed ID: 9274485 [No Abstract] [Full Text] [Related]
15. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C. D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534 [TBL] [Abstract][Full Text] [Related]
16. [Iron storage disease]. Horváth G; Dávid K Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908 [TBL] [Abstract][Full Text] [Related]
17. [Fibrosis in chronic hepatitis C infection: mechanisms and cofactors]. Bedossa P Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B163-7. PubMed ID: 12180284 [No Abstract] [Full Text] [Related]
18. [Hepatitis C, hemochromatosis and porphyria cutanea tarda]. Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178 [TBL] [Abstract][Full Text] [Related]
19. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C. Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478 [TBL] [Abstract][Full Text] [Related]
20. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]